Fas ligand (FasL, CD95L) belongs to the tumor necrosis factor (TNF) family, and has a well-characterized role in inducing apoptosis in target cells by crosslinking the receptor, Fas (CD95), on the cell surface. 1 Deficiency of FasL can lead to autoimmunity in humans and mice on certain genetic backgrounds, due to the lack of activation-induced cell death of T lymphocytes. 2 However, paradoxically, deficiency of FasL has also been associated with protection from inflammation. FasL is involved in apoptosis of mesangial cells by macrophages. 3 Non-apoptotic functions of FasL including cell survival and migration, nuclear factor kappa B activation, and cytokine release are increasingly recognized. 4, 5 Soluble FasL has been implicated in chemotaxis of neutrophils and monocytes. [6] [7] [8] FasL also has been implicated in facilitating the release of cytokines such as monocyte chemoattractive protein (MCP)-1, interleukin (IL)-6, and IL-12 in response to IL-1 and Toll-like receptor 4 stimulation. [9] [10] [11] FasL is expressed in the kidney in human glomerulonephritis and animal models of glomerulonephritis, 12, 13 but its functional effects are not known. We therefore set out to determine the role of FasL in nephrotoxic nephritis and to determine the relative roles of FasL expression on circulating and intrinsic renal cells.
Generalized lymphoproliferative disorder (GLD) mice have a defective form of FasL with a point mutation in the extracellular region of FasL, 2, 14 affecting the binding of the protein to Fas. On permissive genetic backgrounds (for example, MRL), GLD mice developed lymphadenopathy, splenomegaly, and autoimmunity. However, in other strains (for example, C57BL/6), a defective Fas/FasL system induced autoantibodies, but only mild glomerulonephritis. 15 We have used mice on a C57BL/6 background for these studies.
RESULTS
GLD mice on a C57BL/6 background developed glomerular immune complex deposition, but no significant renal damage during the time course of the NTN experiments Mice used in the nephrotoxic nephritis (NTN) experiments were between 2 and 4 months of age. We therefore investigated GLD mice of these ages for evidence of spontaneous renal disease. At 2 months, histology and immunofluorescence of the GLD mice were normal. At 4 months, there was some granular immunoglobulin (Ig)G deposited in the glomeruli, but the kidneys were histologically normal (Supplementary Figure S1 online). There was no albuminuria or renal dysfunction in any of the groups and no significant difference in glomerular macrophage numbers between GLD and WT at 2 and 4 months (Table 1 ). There were no crescents or glomerular thrombosis in unmanipulated wild-type (WT) and GLD mice at 2 and 4 months. 8)). FasL-defective GLD mice were strongly protected from renal injury compared with WT mice, in terms of glomerular thrombosis (Po0.01), glomerular crescents (Po0.001), albuminuria (Po0.001), serum albumin (Po0.001), and serum urea (Po0.01). TUNEL staining revealed lower numbers of glomerular apoptotic cells in the GLD than in the WT mice (Po0.001; Figure 1f ).
There was no reduction in glomerular neutrophil or macrophage infiltration, but interstitial inflammation was reduced in GLD mice Despite protection from injury, the GLD mice had a macrophage infiltrate in the glomeruli that was not significantly different from WT nephritic mice (median 1.86 versus 1.24 CD68-positive cells/glomerular cross-section in WT versus GLD, not significant; Figures 2 and 3a) . In contrast, in the interstitial regions, there was a reduction in the macrophage infiltration in the GLD mice compared with WT (Po0.01, Figures 2 and 3b ). This was mirrored by reduced MCP-1 mRNA in whole-kidney mRNA extracts at Day 15 (Figure 3c , Po0.001). At 24 h after injection of nephrotoxic serum, there was no significant difference in the glomerular neutrophil infiltrate between WT and GLD mice ( Figure 3d ), although there was a wide range, possibly because of the transient nature of the neutrophil population.
Antibody and T-cell responses to the nephritogenic antigen
To determine the mechanism for the protection of disease, the systemic and local immune responses were analyzed. Murine IgG deposited in glomeruli was quantified at Day 1, Day 8, and Day 15 after the induction of disease. Compared with WT, there was a delay in the glomerular antibody deposition in GLD mice, as there was significantly less in GLD glomeruli at Day 1 (Po0.01), no difference at Day 8 and more mouse IgG (Po0.01) deposited at Day 15 after induction of disease ( Figure 4a ). Similarly, in terms of circulating mouse anti-sheep IgG, there was no significant difference between WT and GLD at Day 1, but relative to WT, there was significantly more circulating anti-sheep IgG at Day 8 and Day 15 in the GLD mice (Po0.05 and Po0.01, respectively; Figure 4b ).
Splenocyte proliferation to sheep IgG was determined after preimmunization only (primary immune response) and in a separate experiment at the termination (Day 10). There was reduced splenocyte proliferation to antigen in the GLD mice after preimmunization alone ( Figure 5a ); however, by the end of the experiment, the proliferation was equal between WT and GLD ( Figure 5b ). Analysis of cytokines produced by splenocytes after preimmunization and rechallenge with sheep IgG in vitro showed reduced interferon gamma (IFN-g) production by GLD splenocytes (Po0.05) and a tendency to a reduced IL-17A production (P ¼ 0.09; Figure 5a ). In the Day-10 experiment, the supernatant IFN-g production was below the limit for detection by the enzymelinked immunosorbent assay (ELISA). The IL-4 production by splenocytes in response to sheep IgG was barely above the detection limit of the assay, and not significantly different between the two groups. Therefore, there was a defect in T-cell responses early in the phase of the disease, although this was not evident at Day 10 post NTN.
To investigate this further, intrarenal T cells and cytokines were analyzed. There was a reduction in CD4-positive T-cell infiltration in the GLD mice at Day 15 after induction of NTN (median 0.38 (interquartile range 0.19-0.57) CD4positive T cells/glomerular cross-section in the WT mice versus 0.19 (0.1-0.23) CD4 þ cells/glomerular cross-section in the GLD mice; Figure 6a ). In parallel with this observation, we saw reduced mRNA for IFN-g in the kidneys of the nephritic GLD mice (Po0.05, Figure 6b ). IL-4 mRNA was downregulated in nephritic kidneys compared with nondiseased kidneys, and there was no significant difference between WT and GLD nephritic mice ( Figure 6c ). mRNA for IL-12p40, a component of IL-12 and IL-23, was significantly reduced in the GLD kidneys compared with WT nephritic kidneys (Po0.001, Figure 6d ). Taken together, there was a moderate reduction in the systemic T-cell response at an early stage of NTN, but not at later.
Fas ligand derived from either bone marrow-derived or radioresistant intrinsic renal cells was sufficient to restore susceptibility to NTN Bone marrow transplant experiments were conducted to compare the role of bone marrow-derived and radioresistant cell expression of FasL. GLD mice were transplanted with WT bone marrow and WT mice were transplanted with GLD bone marrow, as well as isografts performed as controls. To assess reconstitution of circulating leukocytes, mice were transplanted with bone marrow marked with the allotype marker CD45.1 rather than CD45.2, the C57BL/6 allotype. A median of 92.2% (range 90.9-93.4%) of CD45-positive circulating leukocytes were of CD45.1 donor origin, as opposed to the recipient CD45.2 cells in peripheral blood at 8 weeks after bone marrow transplantation (Supplementary Figure S3 online). Semiquantitative PCR of DNA extracted from whole blood at the termination of the experiments was compared with a standard curve of known mixtures of WT and GLD DNA. More than 95% of DNA extracted from circulating blood was of donor origin in both the WT to GLD and the GLD to WT transplants (not shown).
Ten weeks post bone marrow transplantation, mice were induced with NTN, and were killed at Day 8 after the injection of nephrotoxic serum. WT bone marrow restored disease susceptibility, as GLD mice transplanted with WT bone marrow had more renal damage than GLD mice transplanted with GLD bone marrow (Po0.05 for glomerular thrombosis, crescents, serum urea, and urinary albumin/ creatinine ratios; Figure 7a-d). As noted in previous experiments, there was no significant difference in the glomerular macrophage infiltrate between any of the groups, but there were reduced interstitial macrophages, only in the GLD to GLD transplants (not shown). Only the GLD to GLD transplants had reduced levels of glomerular apoptosis ( Figure 7f ). However, our results suggest that FasL expression by radioresistant cells in the kidney is also sufficient to induce renal injury in NTN, as WT mice transplanted with GLD bone marrow were not protected from NTN as compared with WT mice transplanted with WT bone marrow ( Figure 7 ). To determine whether there was chimerism of resident kidney leukocytes post bone marrow transplantation, C57BL/6 (CD45.2) mice were transplanted with CD45.1 bone marrow using the same protocol. Ten weeks later, kidney cells were dissociated, stained for CD45.1, CD45.2, F4/80, and CD11c, and analyzed by flow cytometry (n ¼ 7). The chimerism of resident kidney cells was broadly similar to blood with total leukocytes median 88% (range 87.3-91.8%), CD11c þ F4/80 þ 95.4 (92.3-95.6), and CD11c þ F4/80À 93.4% (90.7-96.3%), Supplementary Figure S3 online. These results suggest a role for intrinsic renal cell FasL in NTN pathogenesis.
FasL mRNA increases in the kidney during NTN, and is expressed by cultured mesangial cells mRNA for FasL was increased in whole-kidney lysates after the development of NTN, indicating that FasL in the kidney itself could have a local effect ( Figure 8a) ; however, the mRNA results cannot distinguish whether this is originating from circulating or intrinsic renal cells. We therefore assessed the expression of FasL on mesangial cells, cultured overnight in the presence of a metalloproteinase inhibitor to inhibit cleavage to soluble FasL. By flow cytometry, we could detect FasL on 18.4% of the cultured mesangial cells using a FasFc conjugate, compared with 1.96% positive cells with the secondary antibody alone (Figure 8b ). As defective FasL signaling has been associated with reduced responses to IL-1, we then examined MCP-1 secretion by WT and GLD mesangial cells after stimulation with IL-1 or TNF-a. There was significantly reduced MCP-1 secretion by GLD mesangial cells after stimulation with IL-1 but not TNF-a (representative results from one of five experiments for IL-1 and three experiments for TNF-a are shown in Figure 8c and d) .
DISCUSSION
Our results show that FasL mutant (GLD) mice on a C56BL/ 6 background were strongly protected from histological and functional renal injury, using the nephrotoxic nephritis model of glomerulonephritis. T-cell-mediated systemic immunity was reduced in the early phase of the disease, which may have contributed to protection from injury. However, the bone marrow transplant results did not support an exclusive role for FasL expressed by circulating cells in mediating injury, making it less likely that differences in the immune response are completely responsible for the protection of GLD mice from glomerulonephritis. We showed expression of FasL in the kidney in NTN, and our results would suggest that local expression of FasL in the kidney by circulating or intrinsic renal cells can facilitate injury in this model.
GLD mice have been found to be protected from a number of models of injury. 10, [16] [17] [18] [19] Similar to our findings, T-cell proliferation to antigen was not reduced at the end of the experiments in either collagen-induced arthritis 10 or experimental allergic encephalomyelitis. 18 In these models, the immune response at earlier stages of disease was not examined.
A Th2-deviated immune response protects from murine nephrotoxic nephritis. 20 Th2-deviated immune responses have been found in human patients with Fas and FasL mutations causing autoimmune lymphoproliferative syndrome. 11 We noted significantly increased IL-4 production by GLD splenocytes after polyclonal stimulation (data not shown).
However, we could not demonstrate enhanced antigenspecific Th2 responses systemically or in the kidney, and thus this mechanism is unlikely to explain protection from disease in our model.
Interestingly, there was no reduction in glomerular macrophage or neutrophil infiltration into glomeruli in GLD mice with NTN. Although FasL is involved in migration of neutrophils 6, 7 and macrophages 8 to inflammatory sites, FasL does not have a major role in the entry of inflammatory cells to glomeruli in this model. It is likely that other mechanisms such as Fc receptor-or complement-mediated events have a larger role in models in which immune complexes are deposited.
It is striking that the glomerular injury and subsequent interstitial injury and inflammation was markedly reduced, despite the lack of reduction in glomerular macrophage infiltration. This suggests that in the absence of functional FasL, the ability of the cells to induce glomerular damage was reduced. We saw reduced apoptotic bodies in the kidneys of the GLD mice induced with NTN. FasL induces apoptosis of cells, including mesangial cells. 3 The reduction in apoptosis may be responsible for protection from injury. An alternative possibility is that the presence of FasL in the glomerulus is involved in cell activation. Indeed, FasL has been reported to function synergistically with IFN-g to enhance macrophage activation. 21 In addition, FasL can activate the intracellular a b d c WT nil GLD nil WT IL-1 GLD IL-1 WT nil GLD nil WT TNF GLD TNF mediator nuclear factor kappa B, a key transcription factor for inflammatory responses, 22 and facilitates signaling through the IL-1 receptor. 10 Binding of FasL to Fas activates caspases, which process IL-1b for secretion. Transplantation of WT bone marrow to GLD mice was sufficient to restore susceptibility to NTN, indicating that expression of FasL by circulating cells was sufficient to induce NTN. However, transplantation of GLD bone marrow to WT mice did not protect from disease, despite good deletion of circulating WT bone marrow-derived cells. There were some (B10%) WT circulating and intrinsic renal cells present in these bone marrow transplants, and we cannot exclude the possibility that these are sufficient to induce disease. However, a lack of reduction of disease does suggest that there is a source of FasL from radioresistant cells in the kidney that is permissive for the development of NTN. This is in contrast to results from similar experiments conducted in experimental allergic encephalomyelitis and uveitis, where FasL expressed on circulating cells was responsible for protection from disease. 19, 23 We confirm that mesangial cells in vitro express FasL. FasL on intrinsic renal cells is functional, as there is a previous report of a functional role for FasL expression by tubular cells in inducing apoptosis of surrounding tubular cells in a model of cisplatin-induced acute tubular necrosis. 24 A role for FasL on intrinsic renal cells in glomerulonephritis has not been previously shown. GLD mesangial cells had attenuated responses to IL-1-b in terms of the production of MCP-1 in vitro, consistent with previous reports in other cell types expressing FasL. 10, 25 There was a large reduction in mRNA for MCP-1 in the GLD kidneys, consistent with this finding, and a large reduction in macrophages in the interstitium, which may indicate that similar mechanisms operate to regulate MCP-1 production in the interstitial compartment. MCP-1 is involved in cell activation and chemotaxis. 26 The autoimmunity-enhancing effects of FasL blockade may preclude its use as a therapeutic agent. However, this study highlights the importance of FasL in renal injury and highlights a possible role for intrinsic renal cell FasL expression in the pathogenesis of glomerulonephritis.
MATERIALS AND METHODS
Mice GLD mice on a C57BL/6 background were purchased from Jackson Laboratory (Maine, ME) and bred in-house, and C57BL/6 WT mice were purchased from Harlan (Blackthorn, UK). Animal experiments were conducted according to the institutional and the UK Home Office guidelines. Mice were genotyped using a protocol available on the Jackson Laboratory website. Experimental groups were matched for sex and age.
Induction of nephrotoxic nephritis
Sheep anti-mouse nephrotoxic globulin was prepared as described previously. 27 The endotoxin content of the nephrotoxic globulin was undetectable, measured using a Biowhittaker 1000-QCL LPS assay kit (Biowhittaker, Walkersville, MD). Mice were immunized intraperitoneally with 0.2 mg of sheep IgG in a 50:50 mix of saline and complete Freund's adjuvant (Sigma Chemical, St Louis, MO). Five days later, 0.2 ml of nephrotoxic globulin was injected intravenously. Mice were monitored clinically and the experiments were terminated if the mice were showing signs of the disease.
Histological studies and quantitative immunofluorescence Glomerular crescents and thrombosis were scored on samples fixed in Bouin's solution and stained with periodic acid-Schiff, by an observer blinded to the experimental group. Glomerular thrombosis was assessed by scoring individual glomeruli for periodic acid-Schiff-positive material as follows: grade 0: no periodic acid-Schiffpositive material; grade 1: 0-25% of glomerular cross-section periodic acid-Schiff positive; grade 2: 25-50%; grade 3: 50-75%; grade 4: 75-100%. Fifty glomeruli were scored per kidney. Glomerular crescents were defined as glomeruli containing two or more layers of cells in Bowman's space.
Glomerular mouse and sheep IgG were visualized by direct immunofluorescence on frozen kidney sections using fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Fc-specific) and fluorescein isothiocyanate-conjugated monoclonal mouse anti-sheep IgG clone GT34 (Sigma, Dorset, UK). To quantify immunofluorescence, sections were examined at Â 40 magnification using an Olympus BX4 fluorescence microscope (Olympus Optical, London, UK) and a Photonic Science Colour Coolview camera (Photonic Science, Robertsbridge, UK). Samples from each experiment were stained on the same occasion and measured together. Images of the sections were captured using Image Pro (MediaCybernetics, Bethesda, MD) and the total pixel intensity for each glomerulus was measured and averaged for 20 glomeruli per section.
For cell markers, kidneys were fixed in periodate-lysineparaformaldehyde. Sections of 5 mm were stained for macrophages with FA11 (monoclonal rat anti-mouse CD68, Serotec, Oxford, UK) or CD4 cells (GK1.5, BDPharmingen, Oxford, UK), and developed using the Polink-2 plus HRP rat detection kit (Newmarket Scientific, Newmarket, UK). Macrophages and T cells in 50 glomeruli/sample were counted and averaged to obtain cells/glomerular per crosssection. For interstitial macrophage infiltration, five high-power fields per kidney were photographed. The proportion of the pictures with brown peroxidise pigmentation was calculated using the ImagePro software (MediaCybernetics) and averaged for the five high-power fields. All slides from a single experiment were analyzed simultaneously TUNEL staining was used to detect apoptotic cells on formalin-fixed sections of mouse kidney using the ApopTag Fluorescein Kit (Qbiogene, Carlsbad, CA).
Quantitative RT-PCR Total RNA was extracted from whole kidneys using the TRIzol method. Real-time qRT-PCR was performed on an ABI 7500 Sequence Detection System (Applied Biosystems, Warrington, UK) using Brilliant II SYBR Green qRT-PCR Master Mix, 1
Step (Stratagene, Cambridge, UK). RNA was used at a final concentration of 5-10 ng/ml and all samples were run in duplicates. Results were exported to the 7500 Fast System SDS software (Applied Biosystems), and C t values were determined for all the genes analyzed. The relative expression levels, normalized to GAPDH gene expression, were determined by using the 2 ÀDDCt method. The following primers were used: MCP-1 forward: 5 0 -ATGCAGTTAATGCCC CACTC-3 0 ; MCP-1 reverse: 5 0 -AGCTGGAAGCCACTGACACT-3 0 ; GAPDH forward: 5 0 -GGGTGTGAACCACGAGAAAT-3 0 ; GAPDH reverse: 5 0 -GTCTTCTGGGTGGCAGTGAT-3 0 ; IFN-g forward: 5 0 -GCA TCTTGGCTTTGCAGCTC-3 0 ; IFN-g reverse: 5 0 -CGACTCC TTTTCCGCTTCCT-3 0 ; IL-4 forward: 5 0 -ACAGGAGAAGGGACGC CAT-3 0 ; IL-4 reverse: 5 0 -GAAGCCCTACAGACGAGCTCA; IL-12-p40 forward: 5 0 -GGAAGCACGGCAGCAGAATA-3 0 ; IL-12-p40 reverse: 5 0 -AACTTGAGGGAGAAGTAGGAAT-3 0 ; FasL forward: 5 0 -ACCCCCACTCAAGGTCCAT-3 0 ; FasL reverse: 5 0 -CGAAGTAC AACCCAGTTTCGT-3 0 .
Serum urea, albumin, and urinary albumin/creatinine ratio Serum urea and urinary creatinine were measured in the Department of Clinical Chemistry, Imperial College Healthcare NHS Trust. Serum albumin was measured using the AssayMax mouse albumin ELISA kit (AsssayPro, St Charles, MO). Albuminuria was assessed by radial immunodiffusion against a rabbit anti-mouse albumin (Biogenesis, Poole, UK), as previously described. 27 Circulating antibody and T-cell immune responses Serum mouse anti-sheep IgG levels were measured by sandwich ELISA as previously described. 27 Detecting antibody for IgG (g-chain specific) was obtained from Sigma. Samples were tested in duplicate at 1:500 and 1:1000 dilutions. Background fluorescence in uncoated wells was subtracted, and normal serum from unimmunized mice served as a control.
For splenocyte proliferation assays, single-cell suspensions were created and red cells were lysed. Cells were cultured at 1 Â 10 6 cells/ml for 72 h in HL1 serum-free medium (Lonza, Basel, Switzerland), in the presence or absence of 100 ng/ml heat-aggregated sheep IgG, or 100 ng/ml phorbol myristate acetate plus ionomycin (500 ng/ml) as a positive control. At 72 h, 1 mCi/well 3 H thymidine was added for 24 h before assessing splenocyte proliferation using standard procedures and a Wallac 1450 microbeta counter (Perkin Elmer, Waltham, MA). Supernatants collected at 72 h were assayed for IL-4 and IFN-g using ELISA kits, according to the manufacturer's instructions (eBioscience, Hatfield, UK), and IL-17alpha (R&D Systems, Minneapolis, MN). Lower limits for detection were 1, 15, and 15 pg/ml.
Bone marrow chimeras
Chimeric mice were made by irradiation with a dose of 8 Gy and reconstituted with 10 Â 10 6 donor bone marrow cells. Nephritis experiments were conducted at 10 weeks after this. Confirmation of chimerism was obtained using PCR on DNA extracted from 0.1 ml blood obtained at the terminal bleed. PCR was performed as recommended on the Jackson laboratory website, except that the reverse primer was labeled with the fluorescent marker 6-carboxyfluoroscein. The products were run on Genescan (Applied Biosystems) and the ratio of the mutant (108 bp) versus WT (88 bp) product was calculated and compared with known mixtures of WT and GLD DNA (0, 5, 50, 90, 95, and 100% mutant DNA). In addition, to confirm chimerism, blood was taken from mice transplanted with CD45.1 allotype bone marrow and the mice were bled at 10 weeks post transplantation. Red cells were lysed, and Fc receptors were blocked with 2.4G2 and stained with CD45.1 APC and CD45.2 APC. Kidney single-cell suspensions were prepared as previously described. 28 Briefly, kidneys were removed and sliced into six pieces using a scalpel, followed by digestion with DNase I 100 and 0.5 mg/ml Collagenase D (Roche Diagnostics, Burgess Hill, UK). Kidneys were mashed and filtered through a 100-mm nylon mesh. Kidney suspensions were incubated with 2.4G2 (eBiosciences) to block Fc receptors, and then stained with the following antibodies obtained from eBiosciences: APC-CD45.1, PE-CD45.2, fluorescein isothiocyanate F4/80, and PerCP Cy5.5 CD11c. Flow cytometry was performed using a FACScalibur flow cytometer and analyzed using the FlowJo (TreeStar, Ashland, OR) software.
Mesangial cell cultures
Glomeruli were collected from WT and GLD kidneys and digested with collagenase as previously described. 29 Mesangial cells were cultured in RPMI containing 20% fetal calf serum, and passaged 8-12 times before use. Mesangial cells were characterized as antimyosin positive, CD11b, and pancytokeratin negative, with characteristic stellate morphology. Briefly, 10 6 cells/well were cultured in a six-well plate (Nunc, Rochester, NY) for 24 h, after which the cells were serum-starved overnight. Cells were stimulated with 10 ng/ml IL-1b, TNF-a, or left unstimulated in serum-free mesangial media for 24 h. Supernatant MCP-1 levels were analyzed by ELISA according to the manufacturer's instructions (eBioscience). Cytokine levels were corrected for cell numbers and were compared with the end of the experiment using the MTT assay according to the manufacturer's instructions (Sigma). There tended to be more cells in the GLD wells at the termination of the experiments, possibly because of reduced apoptosis in these cells.
Mesangial cell FasL expression
Mesangial cells were cultured in the presence of 10 mmol/l GM6001 (Sigma) for 24 h before collecting (protease inhibitor to prevent cleavage of membrane-bound FasL). Cells were collected using Cell Dissociation Solution (Sigma), and nonspecific binding was blocked using 10% normal mouse serum. A measure of 1 mg FasFc conjugate (Sigma) was added to 0.5 Â 10 6 cells, followed by washing in phosphate-buffered saline/1% fetal calf serum. Bound FasFc was detected using fluorescein isothiocyanate-conjugated antihuman IgG (Sigma). Flow cytometry was performed using a FACSCalibur flow cytometer and analyzed using the FlowJo (TreeStar) software.
Statistics
Results are quoted as median (interquartile range), unless otherwise stated. Lines on graphs represent median value. For comparing two groups, the Mann-Whitney U-test was used, and for three or more groups a one-way analysis of variance with Bonferroni's post test was used. GraphPad Prism (GraphPad Software, San Diego, CA) was used to analyze the data. Differences were considered significant when Po0.05.
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